Scarica l'app Stockscreener
0.459
1.29%
-0.006
Precedente Chiudi:
$0.465
Aprire:
$0.45
Volume 24 ore:
28.94M
Relative Volume:
13.66
Capitalizzazione di mercato:
$18.65M
Reddito:
$656.60K
Utile/perdita netta:
$-16.79M
Rapporto P/E:
-0.4273
EPS:
-1.0743
Flusso di cassa netto:
$-11.12M
1 W Prestazione:
+20.76%
1M Prestazione:
+17.99%
6M Prestazione:
+6.00%
1 anno Prestazione:
-62.07%
Intervallo 1D:
$0.41
$0.4668
Intervallo di 1 settimana:
$0.3644
$0.4694
Portata 52W:
$0.2382
$2.60
Scienture Holdings Inc Stock (SCNX) Company Profile
Nome
Scienture Holdings Inc
Settore
Industria
Telefono
(800) 261 0281
Indirizzo
20 AUSTIN BLVD., COMMACK
Compare SCNX vs HITI, PETS, POM, MEDS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SCNX
Scienture Holdings Inc
|
0.459 | 18.28M | 656.60K | -16.79M | -11.12M | -1.0743 |
HITI
High Tide Inc
|
2.35 | 204.74M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.825 | 42.96M | 179.02M | -57.29M | -33.01M | -2.7487 |
POM
Pomdoctor Ltd Adr
|
0.9675 | 7.27M | 0 | 0 | 0 | 0.00 |
MEDS
Trxade Health Inc
|
1.48 | 3.79M | 7.15M | 4.03M | -11.33M | -5.40 |
Scienture Holdings Inc Borsa (SCNX) Ultime notizie
Scienture Holdings 2Q Loss/Shr 7c >SCNX - Moomoo
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
SCNX Q2'26 Earnings: EPS estimate is (0.09) USD - TradingView
Scienture Holdings: Q2 Earnings Snapshot - marketscreener.com
Scienture Holdings (SCNX) grows ARBLI revenue but remains loss-making in Q2 2026 - Stock Titan
SCIENTURE Launches REZENOPY as Second FDA-Approved Commercial Product - Yahoo Finance
Scienture launches naloxone nasal spray for opioid overdose By Investing.com - Investing.com Nigeria
Scienture launches naloxone nasal spray for opioid overdose - Investing.com
SCIENTURE Announces Commercial Launch and Fulfillment of Initial Purchase Orders of REZENOPY™, the Highest Dose FDA-Approved Naloxone Nasal Spray - marketscreener.com
Scienture Holdings Announces Commercial Launch and Fulfillment of Initial Purchase Orders of Rezenopy Nasal Spray 10 Mg - marketscreener.com
EXCLUSIVE: Scienture Launches Highest-Dose Naloxone Nasal Spray Rezenopy in US - Benzinga
Scienture Holdings Inc expected to post a loss of 23 cents a shareEarnings Preview - TradingView
Scienture Holdings Inc (SCNX) Stock News Today - tradingkey.com
Scienture Holdings Inc (SCNX) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Scienture Holdings (SCNX) Holds Near $0.38 as Trading Range Tightens Between $0.36 Support and $0.40 ResistanceComposite Profile - dars.gov.et
Scienture Holdings, Inc. (NASDAQ: SCNX) Stock Price, News & Analysis - Kalkine
Scienture Holdings, Inc. Revenue Breakdown – NASDAQ:SCNX - TradingView
Scienture Holdings Inc (SCNX) Cash Flow - tradingkey.com
When Will Scienture Holdings, Inc. (NASDAQ:SCNX) Become Profitable? - simplywall.st
Scienture Holdings Inc (SCNX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Scienture Holdings Inc (SCNX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Scienture Holdings Inc (SCNX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Enterprise value to EBITDA forward of Scienture Holdings, Inc. – NASDAQ:SCNX - TradingView
Scienture Holdings (SCNX) Slips 5.6%: Testing Key Support at $0.35Bearish Pattern Stocks - dars.gov.et
Scienture Holdings Inc (SCNX) Balance Sheet - TradingKey
Scienture Holdings Inc (SCNX) Income Statement - TradingKey
Scienture Holdings Inc (SCNX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SCNX|Scienture Holdings Inc|Price:0.370|Chg%:+0.001 - TradingKey
Scienture Holdings Inc (SCNX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
SCNX|Scienture Holdings Inc|Price:0.372|Chg%:+0.003 - TradingKey
SCNX|Scienture Holdings Inc|Price:0.357|Chg%:-0.012 - TradingKey
Scienture Holdings Inc (SCNX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Scienture Holdings (SCNX) Faces Modest Decline, Testing Key Support at $0.37PCR Divergence - dars.gov.et
DataMEDS AI Intends to Target GLP-1 Muscle Loss and Long COVID - Stock Titan
SCNX SEC FilingsScienture Holdings, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Scienture completes manufacturing for naloxone spray launch By Investing.com - Investing.com Nigeria
Scienture Holdings Inc. (SCNX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Stock ReactionConsensus Beat Rate - dars.gov.et
$Scienture Holdings (SCNX.US)$ - Moomoo
Scienture Holdings stock jumps over 20% pre-market: Here's why - MSN
Scienture Holdings Company Profile & Introduction - Moomoo
Maxim Group Maintains Scienture Holdings(SCNX.US) With Buy Rating, Maintains Target Price $1.5 - Moomoo
Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX) - The Globe and Mail
Scienture Holdings Stock Jumps Over 20% Pre-Market: Here's Why - Sahm
Scienture Holdings (SCNX) Registration filing Summary - Quartr
The trading volume of these stocks is deviating from the norm in today's session. - ChartMill
Scienture Holdings, Inc. Completes Manufacturing of Commercial Launch Inventory and Begins Shipments of Rezenopy Nasal Spray 10 Mg to U.S. Pharmaceutical Wholesalers - marketscreener.com
Scienture (SCNX) Prepares for Rezonopy Nasal Spray Launch - GuruFocus
Discover the top movers in Thursday's pre-market session. - ChartMill
Scienture completes manufacturing for naloxone spray launch - Investing.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers - marketscreener.com
SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY (Naloxone Hydrochloride) to Wholesalers - Moomoo
Scienture Holdings Inc Azioni (SCNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.15%
1.29%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):